Table 3.
Rate of reperfusion hemorrhage (total and symptomatic) stratified by type of device used and by adjunctive administration of fibrinolytic therapy. IVT, IV thrombolysis; IAF, IA fibrinolysis.
| Total Reperfusion Hemorrhage | Symptomatic Reperfusion Hemorrhage | |||
|---|---|---|---|---|
| Total | 44/84 | 52.4% | 13/84 | 15.5% |
| With IVT | 18/31 | 58.1% | 7/31 | 22.6% |
| Without IVT | 26/53 | 49.1% | 6/53 | 11.3% |
| With IAF | 14/27 | 51.9% | 5/27 | 18.5% |
| Without IAF | 30/57 | 52.6% | 8/57 | 14.0% |
| Distally deployed device | 5/9 | 55.6% | 1/9 | 11.1% |
| Proximally deployed device | 29/57 | 50.9% | 9/57 | 15.8% |
| Combined proximally and distally deployed devices | 3/7 | 42.9% | 1/7 | 14.3% |
| Intra-clot deployed device | 7/11 | 63.6% | 2/11 | 18.2% |